Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-01-29 @ 1:17 PM
Study NCT ID:
NCT00375661
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2006-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC
Sponsor:
Organization: